4//SEC Filing
TAGLIAFERRI MARY 4
Accession 0001104659-24-034565
CIK 0001722964other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:01 PM ET
Size
7.9 KB
Accession
0001104659-24-034565
Insider Transaction Report
Form 4
TAGLIAFERRI MARY
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-12+27,900→ 27,900 totalExercise: $16.09Exp: 2034-03-12→ Common Stock (27,900 underlying) - Award
Common Stock
2024-03-12+4,660→ 4,660 total
Footnotes (3)
- [F1]Represents 4,660 restricted stock units ("RSUs") granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting date of the RSUs. The RSUs vest in equal quarterly installments over a three-year period measured from three months following March 12, 2024, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock option shall vest and become exercisable in equal monthly installments over a three-year period measured from one month following March 12, 2024, subject to the Reporting Person's continued service through each applicable vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001323304
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:01 PM ET
- Size
- 7.9 KB